Hongxia Ma
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Infectious Diseases top 1%
- Oncology top 2%
- Epidemiology top 5%
- Topics
- RNA modifications and cancer (71 papers)Cancer-related molecular mechanisms research (65 papers)MicroRNA in disease regulation (31 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hongxia Ma
270 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Molecular Biology 3.7k
- Cancer Research 2.5k
- Infectious Diseases 1.3k
- Oncology 1.1k
- Epidemiology 646
Countries citing papers authored by Hongxia Ma
This map shows the geographic impact of Hongxia Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Ma more than expected).
Fields of papers citing papers by Hongxia Ma
This network shows the impact of papers produced by Hongxia Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Ma. The network helps show where Hongxia Ma may publish in the future.
Co-authorship network of co-authors of Hongxia Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Hongxia Ma. A scholar is included among the top collaborators of Hongxia Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxia Ma. Hongxia Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 6 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 51 | |
| 10 | 65 | |
| 11 | Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine | 1 |
| 12 | 3 | |
| 13 | 11 | |
| 14 | 12 | |
| 15 | 9 | |
| 16 | 3 | |
| 17 | 9 | |
| 18 | [Analysis of the genome sequences of Dengue virus caused an outbreak of Dengue Fever in Henan province, 2013]. | 2 |
| 19 | 44 | |
| 20 | 1 |
About Hongxia Ma
Hongxia Ma is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 278 papers that have together received 7.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (71 papers), Cancer-related molecular mechanisms research (65 papers) and MicroRNA in disease regulation (31 papers). The work is most often cited by research in Cancer Research (2.5k citations), Infectious Diseases (1.3k citations) and Hepatology (492 citations). Hongxia Ma has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhibin Hu, Hongbing Shen, Guangfu Jin, Juncheng Dai, Qingyi Wei, Jiaping Chen, Yijiang Chen, Meng Zhu, Ruifen Miao and Ci Song. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.